Business Strategy and Policy Assignment #1_Company Profile Se ✓ Solved

```html

Select a major US corporation (a publicly held company listed on one of the major stock exchanges), obtain an annual report and perform an analysis of the company and their customers. You should also use this time to begin researching your chosen firm by searching for articles and/or analyst reports from any of the major financial news websites available to you. My suggestion is that you read the annual report of your chosen firm in an effort to determine a general outline of who their customers are, and what dominant business they are in.

Write a profile of your firm and what they do, highlighting any hot button issues that you find. By hot button, I refer to both, any particular aspects of the company that give them some sort of competitive advantage or ‘uniqueness,’ and/or any hot current issue(s) the firm may be facing. You should also take this time to present and analyze the vision and mission of your firm per class discussion. Finally, try to find information relating to their general competitive profile. Some categories to consider include, but are not limited to: Company Profile; Assessment of Vision/Mission (particularly important); Industry/Primary Competitors; Key Products; Identifiable Customer Segments; Success to Date, Hot Current Issues etc.

Your company’s profile MUST include the following basic factual information at the top of the first page: Student Name; Company Name; Industry (The NAICS code and title for your firm’s primary industry); Market (The primary stock market, either NASDAQ or NYSE, where shares are traded); Symbol (Company stock ticker symbol); Revenue (Latest Year).

All research material used MUST be fully cited and documented using the APA format.

Paper For Above Instructions

Pfizer Inc., a major player in the global pharmaceutical market, has a long and storied history that dates back to its founding in 1849. As one of the largest pharmaceutical companies worldwide, Pfizer operates in the industry designated by the NAICS code 446110, primarily engaged in the manufacturing and development of various medications and vaccines. The company is traded on the New York Stock Exchange under the ticker symbol PFE, and in 2019, it reported a revenue of approximately $51.75 billion.

The pharmaceutical giant is known for its extensive portfolio of products that address a wide array of medical needs. Some of the well-known products include Viagra for erectile dysfunction, Lipitor for lowering cholesterol, and Diflucan an antifungal medication. Pfizer’s commitment to innovation is reflected in its investment in research and development, which has allowed the company to remain at the forefront of the pharmaceutical industry. Its mission encapsulates this ethos: to become the world’s most valued to all these people by producing and providing effective and quality healthcare solutions.

In terms of competitive advantages, Pfizer benefits significantly from its established brand reputation, which has been developed over many years of successful product launches and a commitment to quality. The company has also demonstrated resilience by adapting to market shifts, including the recent demands brought on by the COVID-19 pandemic where it played a pivotal role in vaccine development.

Vision and Mission Assessment

The mission of Pfizer Inc. emphasizes its goal to deliver breakthrough innovations that extend and improve the lives of people globally. This mission provides guidance not only in product development but also corporate social responsibility endeavors. Pfizer aims for its products to be accessible and impactful, aligning with the growing awareness of healthcare needs worldwide.

Industry and Primary Competitors

The pharmaceutical industry, characterized by rapid advancements and stringent regulations, presents both challenges and opportunities for Pfizer. The company faces competition from other major pharmaceutical firms like Johnson & Johnson, Merck, and Novartis. The competitive landscape is further complicated by generic drug manufacturers that threaten market share through lower pricing. This type of competition can sometimes result in price wars that squeeze profit margins and create pressure for pricing strategies.

Identifiable Customer Segments

Pfizer's customer base includes hospitals, healthcare professionals, government health organizations, and individual consumers. The company caters to both the private healthcare market and public health organizations, providing essential pharmaceuticals and vaccines. The global need for vaccines and medications has grown, particularly in developing countries where access to healthcare is becoming increasingly important.

Current Issues and Hot Button Topics

One of the pressing current issues for Pfizer relates to the various governments' regulations that impose challenges on the approval and distribution of new drugs. As seen with vaccine approvals during the COVID-19 pandemic, regulatory frameworks can accelerate or hinder market entry for crucial medical products. Moreover, the company must navigate public perception and trust concerning vaccine efficacy and safety, which is vital for its reputation and sales.

Another significant issue includes maintaining a competitive edge through innovation while managing costs associated with research and development. The ability to acquire smaller biotech firms that offer innovative solutions has become a strategic approach to foster growth and maintain market position. This shift towards mergers and acquisitions positions Pfizer to capitalize on new developments and bolster its product pipeline.

Conclusion

In summary, Pfizer Inc. stands as a distinguished leader in the pharmaceutical industry, recognized for its significant contributions to medicine and public health. The successfully navigated challenges such as regulatory hurdles, competition from generics, and public perception all play crucial roles in shaping the company's strategic direction. By adhering to its mission and focusing on innovation, Pfizer aims to continue its path of growth and development in an ever-evolving medical landscape. With a global presence and a commitment to improving health outcomes, Pfizer remains a crucial player in the market.

References

  • Badiani, R., et al. (2020). The impact of government regulations on pharmaceutical innovations. Journal of Regulatory Affairs.

  • Charrua, A. P. D. S., & Pinto, L. (2017). Equity research-Pfizer Inc. Doctoral dissertation, Instituto Superior de Economia e Gestão.

  • King, A. C., Woods, M., et al. (2011). High-throughput measurement, correlation analysis, and machine-learning predictions for pH and thermal stabilities of Pfizer-generated antibodies. Protein Science, 20(9).

  • Pfizer Inc. (2019). Annual Report. Retrieved from Pfizer's official website.

  • Wang, S., & Tang, Y. (2013). Pfizer's growth strategies under different internal and external environments. International Journal of Business and Social Science, 4(16).

  • Pharmaceutical Research and Manufacturers of America (PhRMA). (2021). Facts and Figures 2021.

  • World Health Organization (WHO). (2020). Vaccines and immunization: A global perspective.

  • The Business of Health Care. (2021). The future of vaccines: Opportunities and challenges for major companies.

  • Industry Insider Reports. (2022). Competitive landscape of the pharmaceutical industry.

  • Global Data Reports. (2022). Market analysis of the pharmaceutical industry post-pandemic.

```